Quốc gia: Đức Sàn giao dịch: Frankfurt Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Đức (648)
- {{country.name}}
- Tất cả các quốc gia
- Đức (648)
Frankfurt (648)
Chăm sóc sức khỏe (648)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (648)
Công nghệ sinh học (648)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (648)
- Nhà sản xuất thuốc - Chung (45)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (277)
- Gói y tế (9)
- Cơ sơ chăm sóc y tế (93)
- Nhà bán lẻ thuốc (21)
- Dịch vụ thông tin sức khỏe (81)
- Thiết bị y tế (202)
- Thiết bị & nguồn cung y tế (106)
- Chẩn đoán & nghiên cứu (102)
- Phân phối y tế (22)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.63 0.69 USD |
-0.6
|
$11.27B 12.32B USD | $13.2K 14.42K USD | $0.63 0.69 USD | $0.63 0.69 USD | $11.27B 12.32B USD | 62.87 | $0.01 0.01 USD | |
| CureVac N.V. 5CV.F | $4.66 5.09 USD |
+0.22
|
$1.05B 1.15B USD | $32.04K 35.02K USD | $4.62 5.05 USD | $4.68 5.12 USD | $1.05B 1.15B USD | 5.82 | $0.8 0.87 USD | |
| Valneva SE AYJ.F | $2.54 2.78 USD |
+5.3
|
$439.37M 480.3M USD | $13.39K 14.63K USD | $2.41 2.64 USD | $2.56 2.79 USD | $439.37M 480.3M USD | 0 | -$0.57 -0.6 USD | |
| Ocugen, Inc. 2H51.F | $0.9899 1.08 USD |
+4.32
|
$289.4M 316.36M USD | $11.62K 12.7K USD | $0.92 1.01 USD | $1 1.09 USD | $289.4M 316.36M USD | 0 | -$0.16 -0.1 USD | |
| Immunic, Inc. 10VA.F | $0.6899 0.75 USD |
-0.72
|
$67.19M 73.45M USD | $4K 4.37K USD | $0.67 0.74 USD | $0.6899 0.75 USD | $67.19M 73.45M USD | 0 | -$0.75 -0.8 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| InflaRx N.V. IF0.F | $0.7299 0.8 USD |
+0.69
|
$49.35M 53.95M USD | $200 218.63 USD | $0.7299 0.8 USD | $0.75 0.82 USD | $49.35M 53.95M USD | 0 | -$0.72 -0.7 USD | |
| Alterity Therapeutics Limited PBN.F | $0.004 0.0043 USD |
-33.33
|
$44.46M 48.6M USD | $20K 21.86K USD | $0.004 0.0043 USD | $0.004 0.0043 USD | $44.46M 48.6M USD | 0 | $0 0 USD | |
| Actinogen Medical Limited 3AC.F | $0.01 0.01 USD |
+23.81
|
$41.3M 45.15M USD | $50K 54.66K USD | $0.01 0.01 USD | $0.01 0.01 USD | $41.3M 45.15M USD | 0 | $0 0 USD | |
| Defence Therapeutics Inc. DTC.F | $0.4199 0.45 USD |
-16.63
|
$23.56M 25.76M USD | $26.74K 29.23K USD | $0.4199 0.45 USD | $0.4699 0.51 USD | $23.56M 25.76M USD | 0 | -$0.04 -0.04 USD | |
| Active Biotech AB (publ) BTPC.F | $0.02 0.02 USD |
-13.68
|
$23.27M 25.44M USD | $15K 16.4K USD | $0.02 0.02 USD | $0.02 0.02 USD | $23.27M 25.44M USD | 0 | -$0.01 -0.01 USD | |
| Memphasys Limited IG7.F | $0.002 0.0021 USD |
+33.33
|
$6.62M 7.24M USD | $364.25K 398.17K USD | $0.002 0.0021 USD | $0.002 0.0021 USD | $6.62M 7.24M USD | 0 | $0 0 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
0
|
$5.13M 5.6M USD | $45K 49.19K USD | $0.01 0.01 USD | $0.01 0.01 USD | $5.13M 5.6M USD | 0 | -$0.02 -0.02 USD | |
| Glow Lifetech Corp. 9DO.F | $0.02 0.02 USD |
0
|
$4.56M 4.99M USD | $1K 1.09K USD | $0.02 0.02 USD | $0.02 0.02 USD | $4.56M 4.99M USD | 0 | -$0.02 -0.02 USD | |
| Medigene AG MDG1.F | $0.14 0.15 USD |
+6.44
|
$2.07M 2.26M USD | $7.68K 8.4K USD | $0.13 0.14 USD | $0.14 0.15 USD | $2.07M 2.26M USD | 0 | -$1.25 -1.3 USD | |
| BioSenic S.A. BT1.F | $0.002299 0.0025 USD |
-14.81
|
$1.72M 1.88M USD | $379.19K 414.51K USD | $0.002299 0.0025 USD | $0.002299 0.0025 USD | $1.72M 1.88M USD | 0 | -$0.03 -0.03 USD | |
| Novo Nordisk A/S NOVA.F | $60.7 66.35 USD |
+1.85
|
$270.76B 295.98B USD | $738 806.73 USD | $59.1 64.6 USD | $61.5 67.23 USD | $270.76B 295.98B USD | 19.51 | $3.11 3.4 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $407.15 445.07 USD |
+2.56
|
$104.55B 114.29B USD | $25 27.33 USD | $406.3 444.14 USD | $407.15 445.07 USD | $104.55B 114.29B USD | 0 | -$3.2 -3.4 USD | |
| CSL Limited CSJ.F | $134.82 147.38 USD |
-1.22
|
$66.44B 72.63B USD | $23 25.14 USD | $133.64 146.09 USD | $134.82 147.38 USD | $66.44B 72.63B USD | 29.18 | $4.62 5.05 USD | |
| CSL Limited CSJA.F | $66.5 72.69 USD |
0
|
$66.28B 72.45B USD | $5 5.47 USD | $66.5 72.69 USD | $66.5 72.69 USD | $66.28B 72.45B USD | 28.29 | $2.35 2.57 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $269.9 295.04 USD |
+0.63
|
$35.41B 38.7B USD | $375 409.93 USD | $269.9 295.04 USD | $269.9 295.04 USD | $35.41B 38.7B USD | 0 | -$1.83 -2.0004 USD | |
| UCB SA UNC.F | $170.4 186.27 USD |
+0.09
|
$32.38B 35.4B USD | $310 338.87 USD | $170.4 186.27 USD | $170.4 186.27 USD | $32.38B 35.4B USD | 31.20 | $5.46 5.97 USD | |
| UCB SA UNC0.F | $84 91.82 USD |
+0.6
|
$32.29B 35.3B USD | $50 54.66 USD | $84 91.82 USD | $84 91.82 USD | $32.29B 35.3B USD | 30.65 | $2.74 3 USD | |
| argenx SE 1AEA.F | $466 509.4 USD |
+2.64
|
$28.96B 31.66B USD | $12 13.12 USD | $466 509.4 USD | $466 509.4 USD | $28.96B 31.66B USD | 32.88 | $14.17 15.49 USD | |
| argenx SE 1AE.F | $469.7 513.45 USD |
+2.69
|
$28.82B 31.5B USD | $5 5.47 USD | $465 508.31 USD | $469.7 513.45 USD | $28.82B 31.5B USD | 32.93 | $14.26 15.59 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
0
|
$25.73B 28.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $25.73B 28.13B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49BA.F | $218 238.3 USD |
+0.93
|
$24.6B 26.89B USD | $10 10.93 USD | $218 238.3 USD | $218 238.3 USD | $24.6B 26.89B USD | 0 | -$3 -3.2 USD | |
| BioNTech SE 22UA.F | $97.1 106.14 USD |
+0.88
|
$23.34B 25.52B USD | $642 701.79 USD | $94.7 103.52 USD | $97.1 106.14 USD | $23.34B 25.52B USD | 0 | -$3.18 -3.4 USD | |
| Royalty Pharma plc RPD.F | $30.76 33.62 USD |
+2.47
|
$17.42B 19.05B USD | $114 124.62 USD | $30.2 33.01 USD | $30.76 33.62 USD | $17.42B 19.05B USD | 14.71 | $2.09 2.28 USD | |
| Insmed Incorporated IM8N.F | $81 88.54 USD |
-0.61
|
$15.44B 16.88B USD | $550 601.22 USD | $81 88.54 USD | $81 88.54 USD | $15.44B 16.88B USD | 0 | -$5.09 -5.5 USD | |
| Innovent Biologics, Inc. 6IB.F | $8.65 9.46 USD |
-2.81
|
$14.79B 16.16B USD | $100 109.31 USD | $8.6 9.4 USD | $8.8 9.62 USD | $14.79B 16.16B USD | 0 | -$0.01 -0.01 USD | |
| Verona Pharma plc I9SA.F | $88.8 97.07 USD |
-0.45
|
$11.99B 13.1B USD | $1.99K 2.17K USD | $88.4 96.63 USD | $91.6 100.13 USD | $11.99B 13.1B USD | 0 | -$1.46 -1.5 USD | |
| United Therapeutics Corporation UTH.F | $253.6 277.22 USD |
+1.64
|
$11.45B 12.52B USD | $18 19.68 USD | $253.6 277.22 USD | $253.6 277.22 USD | $11.45B 12.52B USD | 12.00 | $21.12 23.09 USD | |
| Moderna, Inc. 0QF.F | $29.44 32.18 USD |
+4.79
|
$11.38B 12.44B USD | $1.35K 1.48K USD | $27.77 30.36 USD | $29.44 32.18 USD | $11.38B 12.44B USD | 0 | -$7.34 -8.02 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.8 3.06 USD |
+0.54
|
$11.36B 12.42B USD | $6.86K 7.5K USD | $2.75 3 USD | $2.8 3.06 USD | $11.36B 12.42B USD | 31.11 | $0.09 0.1 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.5 6.01 USD |
0
|
$11.33B 12.39B USD | $208 227.37 USD | $5.5 6.01 USD | $5.5 6.01 USD | $11.33B 12.39B USD | 30.55 | $0.18 0.2 USD | |
| Incyte Corporation ICY.F | $58.16 63.58 USD |
+1.18
|
$11.27B 12.32B USD | $198 216.44 USD | $58.16 63.58 USD | $58.16 63.58 USD | $11.27B 12.32B USD | 342.11 | $0.17 0.19 USD | |
| Akeso, Inc. 4RY.F | $11.8 12.9 USD |
0
|
$10.97B 11.99B USD | $120 131.18 USD | $11.7 12.79 USD | $12.1 13.23 USD | $10.97B 11.99B USD | 0 | -$0.07 -0.07 USD | |
| Exelixis, Inc. EX9.F | $37.78 41.3 USD |
+2.83
|
$10.36B 11.33B USD | $1.11K 1.22K USD | $37.1 40.56 USD | $37.1 40.56 USD | $10.36B 11.33B USD | 19.98 | $1.89 2.07 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $51 55.75 USD |
-0.27
|
$9.78B 10.69B USD | $60 65.59 USD | $50.52 55.23 USD | $51 55.75 USD | $9.78B 10.69B USD | 23.28 | $2.19 2.39 USD | |
| Ascendis Pharma A/S A71.F | $147 160.69 USD |
-3.29
|
$8.92B 9.75B USD | $15 16.4 USD | $147 160.69 USD | $147 160.69 USD | $8.92B 9.75B USD | 0 | -$5.69 -6.2 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $39.57 43.26 USD |
+3.75
|
$7.51B 8.21B USD | $494 540.01 USD | $38.8 42.41 USD | $39.57 43.26 USD | $7.51B 8.21B USD | 0 | -$2.95 -3.2 USD | |
| Bio-Techne Corporation TE1.F | $46.4 50.72 USD |
+4.98
|
$7.27B 7.95B USD | $150 163.97 USD | $44 48.1 USD | $46.4 50.72 USD | $7.27B 7.95B USD | 65.35 | $0.71 0.78 USD | |
| Blueprint Medicines Corporation 2L9.F | $109 119.15 USD |
+0.88
|
$7.11B 7.77B USD | $20 21.86 USD | $108.55 118.66 USD | $109 119.15 USD | $7.11B 7.77B USD | 0 | -$2.14 -2.3 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $20.3 22.19 USD |
-0.98
|
$6.95B 7.59B USD | $10 10.93 USD | $20.3 22.19 USD | $20.3 22.19 USD | $6.95B 7.59B USD | 0 | -$4.16 -4.5 USD | |
| Roivant Sciences Ltd. 87S.F | $9.45 10.33 USD |
+3.94
|
$6.52B 7.13B USD | $600 655.88 USD | $9.41 10.29 USD | $9.45 10.33 USD | $6.52B 7.13B USD | 0 | -$0.63 -0.6 USD | |
| Corcept Therapeutics Incorporated HTD.F | $61.34 67.05 USD |
+6.64
|
$6.5B 7.11B USD | $10 10.93 USD | $59.64 65.19 USD | $61.34 67.05 USD | $6.5B 7.11B USD | 61.95 | $0.99 1.08 USD | |
| 3SBio Inc. 83B.F | $2.64 2.89 USD |
-1.49
|
$6.25B 6.84B USD | $1.81K 1.98K USD | $2.58 2.82 USD | $2.64 2.89 USD | $6.25B 6.84B USD | 26.40 | $0.1 0.11 USD | |
| Legend Biotech Corporation 9LB.F | $33.8 36.95 USD |
+1.2
|
$6.22B 6.8B USD | $30 32.79 USD | $33.2 36.29 USD | $33.8 36.95 USD | $6.22B 6.8B USD | 0 | -$0.96 -1.04 USD | |
| Revolution Medicines, Inc. 42Z.F | $32.4 35.42 USD |
+5.19
|
$6.06B 6.62B USD | $100 109.31 USD | $32.4 35.42 USD | $32.4 35.42 USD | $6.06B 6.62B USD | 0 | -$3.44 -3.7 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $266.5 291.32 USD |
+1.91
|
$5.96B 6.52B USD | $17 18.58 USD | $259.7 283.89 USD | $266.5 291.32 USD | $5.96B 6.52B USD | 0 | -$14.17 -15.5 USD | |
| Financière de Tubize SA FTD.F | $133.6 146.04 USD |
-1.18
|
$5.95B 6.5B USD | $70 76.52 USD | $133.6 146.04 USD | $133.6 146.04 USD | $5.95B 6.5B USD | 66.13 | $2.02 2.21 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $48.07 52.55 USD |
+1.2
|
$5.92B 6.47B USD | $100 109.31 USD | $48.07 52.55 USD | $48.07 52.55 USD | $5.92B 6.47B USD | 15.45 | $3.11 3.4 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $96.1 105.05 USD |
+1.01
|
$5.82B 6.36B USD | $10 10.93 USD | $93.66 102.38 USD | $96.1 105.05 USD | $5.82B 6.36B USD | 15.65 | $6.14 6.71 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $36.2 39.57 USD |
-0.98
|
$5.78B 6.31B USD | $40 43.73 USD | $36.2 39.57 USD | $36.2 39.57 USD | $5.78B 6.31B USD | 0 | -$2.47 -2.7 USD | |
| ALK-Abelló A/S 4AJ0.F | $25.76 28.16 USD |
+0.62
|
$5.75B 6.28B USD | $6 6.56 USD | $25.48 27.85 USD | $25.76 28.16 USD | $5.75B 6.28B USD | 46.83 | $0.55 0.6 USD | |
| TG Therapeutics, Inc. NKB2.F | $31.83 34.79 USD |
+5.98
|
$5.09B 5.56B USD | $300 327.94 USD | $31.83 34.79 USD | $31.83 34.79 USD | $5.09B 5.56B USD | 144.65 | $0.22 0.24 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $76.5 83.62 USD |
+26.45
|
$4.87B 5.32B USD | $1 1.09 USD | $75 81.99 USD | $76.5 83.62 USD | $4.87B 5.32B USD | 0 | -$2.23 -2.4 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $94.26 103.04 USD |
0
|
$4.69B 5.12B USD | $20 21.86 USD | $94.26 103.04 USD | $94.26 103.04 USD | $4.69B 5.12B USD | 0 | -$4.72 -5.1 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Vaxcyte, Inc. 5VA.F | $29 31.7 USD |
+7.41
|
$3.94B 4.31B USD | $100 109.31 USD | $29 31.7 USD | $29 31.7 USD | $3.94B 4.31B USD | 0 | -$3.25 -3.5 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Cytokinetics, Incorporated KK3A.F | $30.8 33.67 USD |
+6.21
|
$3.68B 4.02B USD | $150 163.97 USD | $30.8 33.67 USD | $30.8 33.67 USD | $3.68B 4.02B USD | 0 | -$4.45 -4.8 USD | |
| Krystal Biotech, Inc. 4KB.F | $125.4 137.08 USD |
+3.42
|
$3.64B 3.98B USD | $114 124.62 USD | $125.4 137.08 USD | $125.4 137.08 USD | $3.64B 3.98B USD | 36.24 | $3.46 3.78 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $8.55 9.35 USD |
-0.58
|
$3.63B 3.96B USD | $971 1.06K USD | $8.55 9.35 USD | $8.55 9.35 USD | $3.63B 3.96B USD | 25.14 | $0.34 0.37 USD | |
| Camurus AB (publ) 7CA.F | $59.85 65.42 USD |
0
|
$3.56B 3.89B USD | $43 47 USD | $59.85 65.42 USD | $59.85 65.42 USD | $3.56B 3.89B USD | 72.10 | $0.83 0.91 USD | |
| Akero Therapeutics, Inc. 0K4.F | $43.31 47.34 USD |
+0.25
|
$3.52B 3.85B USD | $125 136.64 USD | $43.31 47.34 USD | $43.31 47.34 USD | $3.52B 3.85B USD | 0 | -$3.17 -3.4 USD | |
| Genscript Biotech Corporation G51.F | $1.6 1.74 USD |
-4.66
|
$3.51B 3.84B USD | $2.77K 3.03K USD | $1.6 1.74 USD | $1.6 1.74 USD | $3.51B 3.84B USD | 0 | -$0.07 -0.07 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Merus N.V. 2GH.F | $45.2 49.41 USD |
+2.73
|
$3.42B 3.73B USD | $106 115.87 USD | $45.2 49.41 USD | $45.2 49.41 USD | $3.42B 3.73B USD | 0 | -$3.55 -3.8 USD | |
| Zai Lab Limited 1ZL.F | $29.4 32.14 USD |
0
|
$3.4B 3.72B USD | $230 251.42 USD | $29.4 32.14 USD | $29.4 32.14 USD | $3.4B 3.72B USD | 0 | -$2.13 -2.3 USD | |
| Ascentage Pharma Group International 36X.F | $8.65 9.46 USD |
-1.7
|
$3.06B 3.35B USD | $174 190.21 USD | $8.55 9.35 USD | $8.65 9.46 USD | $3.06B 3.35B USD | 0 | -$0.16 -0.1 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.21 19.9 USD |
+2.33
|
$3.06B 3.34B USD | $100 109.31 USD | $18.21 19.9 USD | $18.21 19.9 USD | $3.06B 3.34B USD | 15.69 | $1.16 1.27 USD | |
| Scholar Rock Holding Corporation 2QK.F | $31.2 34.11 USD |
+6.12
|
$2.99B 3.27B USD | $150 163.97 USD | $31.2 34.11 USD | $31.2 34.11 USD | $2.99B 3.27B USD | 0 | -$2.21 -2.4 USD | |
| Viking Therapeutics, Inc. 1VT.F | $25.72 28.12 USD |
-1.74
|
$2.89B 3.16B USD | $150 163.97 USD | $25.06 27.39 USD | $26.5 28.96 USD | $2.89B 3.16B USD | 0 | -$0.98 -1.07 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $55.3 60.45 USD |
+0.91
|
$2.84B 3.1B USD | $80 87.45 USD | $55.3 60.45 USD | $55.3 60.45 USD | $2.84B 3.1B USD | 20.25 | $2.73 2.98 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $26.8 29.3 USD |
+7.2
|
$2.52B 2.75B USD | $40 43.73 USD | $26.8 29.3 USD | $26.8 29.3 USD | $2.52B 2.75B USD | 0 | -$3.19 -3.4 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $26 28.42 USD |
-22.16
|
$2.46B 2.69B USD | $115 125.71 USD | $26 28.42 USD | $26.4 28.86 USD | $2.46B 2.69B USD | 0 | -$5 -5.4 USD | |
| Everest Medicines Limited 6HN.F | $7.3 7.98 USD |
-2.67
|
$2.42B 2.65B USD | $12 13.12 USD | $7.3 7.98 USD | $7.3 7.98 USD | $2.42B 2.65B USD | 0 | -$0.36 -0.3 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $44.2 48.32 USD |
+5.74
|
$2.28B 2.49B USD | $26 28.42 USD | $44 48.1 USD | $44.2 48.32 USD | $2.28B 2.49B USD | 0 | -$1.36 -1.4 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $18.47 20.18 USD |
+5.48
|
$2.26B 2.47B USD | $52 56.84 USD | $18.47 20.18 USD | $18.47 20.18 USD | $2.26B 2.47B USD | 13.67 | $1.35 1.48 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $15.91 17.39 USD |
+0.03
|
$2.21B 2.41B USD | $100 109.31 USD | $15.91 17.39 USD | $15.91 17.39 USD | $2.21B 2.41B USD | 0 | -$0.95 -1.03 USD | |
| ImmunityBio, Inc. 26CA.F | $2.43 2.66 USD |
+2.7
|
$2.15B 2.36B USD | $1K 1.09K USD | $2.35 2.57 USD | $2.44 2.67 USD | $2.15B 2.36B USD | 0 | -$0.47 -0.5 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $27.6 30.17 USD |
+3.76
|
$2.12B 2.32B USD | $100 109.31 USD | $27.6 30.17 USD | $27.6 30.17 USD | $2.12B 2.32B USD | 0 | -$2.79 -3.04 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.62 17.08 USD |
+7.35
|
$2.06B 2.25B USD | $680 743.33 USD | $15.62 17.08 USD | $15.62 17.08 USD | $2.06B 2.25B USD | 0 | -$1.49 -1.6 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $101 110.41 USD |
-0.98
|
$1.95B 2.13B USD | $20 21.86 USD | $101 110.41 USD | $104 113.69 USD | $1.95B 2.13B USD | 0 | -$5.89 -6.4 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $32.8 35.85 USD |
+7.19
|
$1.91B 2.08B USD | $120 131.18 USD | $32.8 35.85 USD | $32.8 35.85 USD | $1.91B 2.08B USD | 3.42 | $9.59 10.48 USD | |
| Bavarian Nordic A/S BV3.F | $24.23 26.49 USD |
+2.67
|
$1.89B 2.06B USD | $113 123.52 USD | $23.48 25.67 USD | $24.23 26.49 USD | $1.89B 2.06B USD | 11.11 | $2.18 2.38 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.68 13.86 USD |
+4.36
|
$1.84B 2.02B USD | $230 251.42 USD | $12.68 13.86 USD | $12.68 13.86 USD | $1.84B 2.02B USD | 0 | -$2.26 -2.4 USD | |
| BB Biotech AG BBZA.F | $33.5 36.62 USD |
+2.13
|
$1.83B 2B USD | $886 968.52 USD | $32.7 35.75 USD | $33.5 36.62 USD | $1.83B 2B USD | 0 | -$8.25 -9.01 USD | |
| Veracyte, Inc. 12V.F | $22.8 24.92 USD |
+1.79
|
$1.8B 1.97B USD | $250 273.28 USD | $22.8 24.92 USD | $22.8 24.92 USD | $1.8B 1.97B USD | 63.33 | $0.36 0.39 USD | |
| Vericel Corporation ATQP.F | $35 38.26 USD |
+2.94
|
$1.76B 1.93B USD | $3 3.28 USD | $35 38.26 USD | $35 38.26 USD | $1.76B 1.93B USD | 875.00 | $0.04 0.04 USD | |
| Galapagos NV GXE.F | $25.9 28.31 USD |
+5.89
|
$1.71B 1.87B USD | $1K 1.09K USD | $25.1 27.44 USD | $25.9 28.31 USD | $1.71B 1.87B USD | 0 | -$2.73 -2.9 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $19.4 21.21 USD |
+6.59
|
$1.71B 1.86B USD | $150 163.97 USD | $19.4 21.21 USD | $19.4 21.21 USD | $1.71B 1.86B USD | 0 | -$3.06 -3.3 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||